Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
Infectious Diseases and Therapy
|
May 24, 2023
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Lianne Barnieh, Rachel Beckerman, Sushanth Jeyakumar, et al.
Journal of Comparative Effectiveness Research
|
February 6, 2024
Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
Emmanouil Sinakos, Nandita Kachru, Christos Tsoulas, et al.
Journal of Medical Economics
|
April 27, 2021
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population
Deborah A Fisher, Jordan J Karlitz, Sushanth Jeyakumar, et al.
Journal of Medical Economics
|
February 23, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with sickle cell disease with recurrent vaso-occlusive crises in the United States
Andrea Lopez, Michael Gargano, Hongbo Yang, et al.
Journal of Medical Economics
|
April 9, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with transfusion-dependent <b><i>β</i></b>-thalassemia in the United States
Chuka Udeze, Michael Gargano, Hongbo Yang, et al.
MDM Policy & Practice
|
March 31, 2025
The Cost-Effectiveness of Tenofovir Alafenamide for Chronic Hepatitis B Virus in Taiwan
Elise Chia-Hui Tan, Alon Yehoshua, Sushanth Jeyakumar, et al.
Pain Medicine (Malden, Mass.)
|
April 22, 2026
Real World Treatment Patterns Among Patients with Painful Diabetic Peripheral Neuropathy in the United States
Nathaniel M Schuster, Sushanth Jeyakumar, Ann M Menzie, et al.
Scientific Reports
|
June 10, 2022
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis
Rachel Beckerman, Andrea Gori, Sushanth Jeyakumar, et al.
Journal of Medical Economics
|
December 18, 2025
Societal burden of the US opioid epidemic over the next 15 years and the potential impact of effective non-opioid treatments for pain
Jeromie M Ballreich, Sushanth Jeyakumar, Kenna Garrison, et al.
Journal of Medical Economics
|
May 5, 2026
The incidence of opioid use disorder among people with acute and chronic pain managed with prescription opioids in the United States: economic and societal burden
Andrew J Schoenfeld, Sushanth Jeyakumar, Jessica Morlando Geiger, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
Infectious Diseases and Therapy
|
May 24, 2023
Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Lianne Barnieh, Rachel Beckerman, Sushanth Jeyakumar, et al.
Journal of Comparative Effectiveness Research
|
February 6, 2024
Cost-effectiveness of switching from tenofovir disoproxil fumarate to tenofovir alafenamide versus entecavir for chronic hepatitis B patients in Greece
Emmanouil Sinakos, Nandita Kachru, Christos Tsoulas, et al.
Journal of Medical Economics
|
April 27, 2021
Real-world cost-effectiveness of stool-based colorectal cancer screening in a Medicare population
Deborah A Fisher, Jordan J Karlitz, Sushanth Jeyakumar, et al.
Journal of Medical Economics
|
February 23, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with sickle cell disease with recurrent vaso-occlusive crises in the United States
Andrea Lopez, Michael Gargano, Hongbo Yang, et al.
Journal of Medical Economics
|
April 9, 2026
Cost-effectiveness of exagamglogene autotemcel gene-edited therapy in patients with transfusion-dependent <b><i>β</i></b>-thalassemia in the United States
Chuka Udeze, Michael Gargano, Hongbo Yang, et al.
MDM Policy & Practice
|
March 31, 2025
The Cost-Effectiveness of Tenofovir Alafenamide for Chronic Hepatitis B Virus in Taiwan
Elise Chia-Hui Tan, Alon Yehoshua, Sushanth Jeyakumar, et al.
Pain Medicine (Malden, Mass.)
|
April 22, 2026
Real World Treatment Patterns Among Patients with Painful Diabetic Peripheral Neuropathy in the United States
Nathaniel M Schuster, Sushanth Jeyakumar, Ann M Menzie, et al.
Scientific Reports
|
June 10, 2022
Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis
Rachel Beckerman, Andrea Gori, Sushanth Jeyakumar, et al.
Journal of Medical Economics
|
December 18, 2025
Societal burden of the US opioid epidemic over the next 15 years and the potential impact of effective non-opioid treatments for pain
Jeromie M Ballreich, Sushanth Jeyakumar, Kenna Garrison, et al.
Journal of Medical Economics
|
May 5, 2026
The incidence of opioid use disorder among people with acute and chronic pain managed with prescription opioids in the United States: economic and societal burden
Andrew J Schoenfeld, Sushanth Jeyakumar, Jessica Morlando Geiger, et al.
Page
of 2